D-0353-2021 Class II Ongoing

Recalled by Na Na Collection — Elmwood Park, NJ

FDA drug recall D-0353-2021 was initiated by Na Na Collection on Mar 30, 2021 and is designated Class II. Reason for recall: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil. The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
May 5, 2021
Initiation Date
Mar 30, 2021
Voluntary/Mandated
Voluntary: Firm initiated

Product description

PremierZen Platinum 5000, Packaged in paper packaging with a pill blister, 1 capsule per box, Distributed by New Premier Group Los Angeles CA 90006

Reason for recall

Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.

Distribution pattern

Nationwide with the United States

Code information

Lot #: GATCO 01671, Exp Date 12/30/2024 Serial # 728175421856

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0353-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0353-2021. Report a data issue: hello@regdatalab.com.